Control Bionics Ltd. · ASX:CBL

Jeremy Steele received 1,750,000 Control Bionics Ltd. shares as an award (Appendix 3Y, ASX)

Traded Oct 15, 2026 · Filed Oct 15, 2026

On Oct 15, 2026, Jeremy Steele (Director) received 1,750,000 Control Bionics Ltd. shares as an award. Filed Oct 15, 2026 (Appendix 3Y, ASX).

Awarded
1,750,000 shares
Role
Director

The filing in full

Appendix 3Y

*Rule 3.19A.2*

Change of Director’s Interest Notice

*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*

Introduced 30/09/01 Amended 01/01/11

Name of entityCONTROL BIONICS LIMITED
ABN45 115 465 462

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.

Name of DirectorJeremy Steele
Date of last notice12 August 2026

Part 1 - Change of director’s relevant interests in securities

*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.

Direct or indirect interestDirect and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.Shareholder of J STEELE INVESTMENT CORPORATION PTY LTD
Date of change15 October 2026
No. of securities held prior to changeOptions: 12,320,807 Ordinary shares: 4,612,886
ClassOptions
Number acquired1,750,000
Number disposedNil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuationNil
  • See chapter 19 for defined terms.

---

No. of securities held after changeOptions: 14,070,807 Ordinary shares: 4,612,886
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-backIssue of options approved at 2026 AGM

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.

Detail of contractNA
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

+ Part 3 – Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?
  • See chapter 19 for defined terms.

---

  • See chapter 19 for defined terms.
DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 15, 2026OptionsAward1,750,000

Source

Download PDF · View original at ASX

Related